p53 Controls low DNA damage-dependent premeiotic checkpoint and facilitates DNA repair during spermatogenesis

Cell Growth and Differentiation

Volumn 10, Issue 10, 1999, Pages 665-675

  Schwartz, Dov ^a   Goldfinger, Naomi ^a   Kam, Zvi ^a   Rotter, Varda ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; GAMMA IRRADIATION; KNOCKOUT MOUSE; MALE; MEIOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHASE; QUALITY CONTROL; SPERMATOGENESIS; SPERMATOZOON MATURATION; SPERMATOZOON MOTILITY;

ANIMALS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FLOW CYTOMETRY; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; SPERM MOTILITY; SPERMATOGENESIS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0032759922     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Kleckner, N. Meiosis: how could it work? Proc. Natl. Acad. Sci. USA, 93: 8167-8174, 1996.
2. Lane, D. P. p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
3. Rotter, V., Schwarte, D., Almon, E., Goldfinger, N., Kapon, A., Meshorer, A., Donehower, L. A., and Levine, A. J. Mice with reduced levels of p53 exhibit the testicular giant cell degenerative syndrome. Proc. Natl. Acad. Sci. USA, 90: 9075-9079, 1993.
4. Almon, E., Goldfinger, N., Kapon, A., Schwartz, D., Levine, A. J., and Rotter, V. Testicular tissue-specific expression of the p53 suppressor gene. Dev. Biol., 156: 107-116, 1993.
5. Schwartz, D., Goldfinger, N., and Rotter, V. Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene, 8: 1487-1494, 1993.
6. Masters, J. R. W., Osborne, E. J., Walker, M. C., and Parris, C. N. Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs. Int. J. Cancer, 53: 340-346, 1993.
7. Donehower, L. A. The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol., 7: 269-278, 1996.
8. Sjoblom, T., and Lahdetle, J. Expression of p53 in normal and γ-irradiated rat testis suggests a role for p53 in meiotic recombination and repair. Oncogene, 12: 2499-2505, 1996.
9. Chresta, C. M., Masters, J. R. W., and Hickman, J. A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high bax:bcl-2 ratio. Cancer Res., 56: 1834-1841, 1996.
10. Chresta, C. M., and Hickman, J. A. Oddball p53 in testicular tumors. Nat. Med., 2: 745-746, 1996.
11. Lutzker, S. G., and Levine, A. J. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med., 2: 804-810, 1996.
12. Oliver, R. T. Testicular cancer. Curr. Opin. Oncol., 8: 252-258, 1996.
13. Socher, S. A., Yin, Y., Dewolf, W. C., and Morgentaler, A. Temperature-mediated germ cell loss in the testis is associated with altered expression of the cell-cycle regulator p53. J. Urol., 157: 1986-1989, 1997.
14. Oliver, R. T. Testicular cancer. Curr. Opin. Oncol., 9: 287-294, 1997.
15. Hasegawa, M., Zhang, Y., Niibe, H., Terry, N. H., and Meistrich, M. L. Resistance of differentiating spermatogonia to radiation-Induced apoptosis and loss in p53-deficient mice. Radiat. Res., 149: 263-270, 1998.
16. Zamble, D. B., Jacks, T., and Lippard, S. J. p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc. Natl. Acad. Sci. USA, 95: 6163-6168, 1998.
17. Gersten, K. M., and Kemp, C. J. Normal meiotic recombination in p53-deficient mice. Nat. Genet., 17: 378-379, 1997.
18. Odorisio, T., Rodriguez, T. A., Evans, E. P., Clarke, A. R., and Burgoyne, P. S. The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis. Nat. Genet., 18: 257-261, 1998.
19. Yin, Y., Stahl, B.C., DeWolf, W.C., Morgentaler, A. p53-mediated germ cell quality control in spermatogenesis. Dev. Biol., 204: 165-171, 1998.
20. Barlow, C., Liyanage, M., Moens, P. B., Deng, C-X., Ried, T., and Wynshaw-Boris, A. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat. Genet., 17: 462-466, 1997.
21. Fukasawa, K., Wiener, F., Vande Woude, G. F., and Mai, S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Ortcogene, 15: 1295-1302, 1997.
22. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing irradiation: defects in chromosome instability syndromes? Cell, 75: 765-778, 1993.
23. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tisty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
24. Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71: 543-546, 1992.
25. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunket, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell, 71: 587-597, 1992.
26. Agarwal, M. L., Agarwal, A., Taylor, W. R., and Stark, G. R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8493-8497, 1995.
27. 2-dependent immunoglobulin κ light chain gene expression. EMBO J., 14: 1392-1401, 1995.
28. 2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res., 55: 1763-1773, 1995.
29. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reld, B. J. A p53-dependent mouse spindle checkpoint Science (Washington DC), 267: 1353-1356, 1995.
30. Golsteyn, R. M., Mundt, K. E., Fry, A. M., and Nigg, E. A. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J. Cell Biol., 129: 1617-1628, 1995.
31. Wells, W. A. E. The spindle-assembly checkpoint: aiming for a perfect mitosis, every time. Trends Cell Biol., 6: 228-234, 1996.
32. Bates, S., and Vousden, K. H. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6: 12-19, 1996.
33. Kaufmann, W., Levedakou, E., Grady, H., Paules, R., and Stein, G. Attenuation of G2 checkpoint function precedes human immortilization. Cancer Res., 55: 7-11, 1995.
34. Wang, X. W., Vermwulen, W., Coursen, J. D., Gibson, M., Lupold, S. E., Forrester, K., Xu, G., Elmore, L., Yen, H., Hoeijmakers, J. H. J., and Harris, C. C. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev., 10: 1219-1232, 1996.
35. Dutta, A., Ruppert, J. M., Aster, J. C., and Wincherester, E. Inhibition of DNA replication factor RPA by p53. Nature (Lond.), 365: 79-82, 1993.
36. Sturzbecher, H-W., Donzelmann, B., Henning, W., Knippschild, U., and Buchhop, S, p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J., 15: 1992-2002, 1996.
37. Lim, D., and Hasty, P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol., 16: 7133-7143, 1996.
38. Xu, Y., Ashley, T., Brainerd, E. E., Bronson, R. T., Meyn, M. S., and Baltimore, D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev., 10: 2411-2422, 1996.
39. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, N. J., Ried, T., Tagle, D., and Wynshaw-Boris, A. Atm-defictent mice: a paradigm of ataxia telangiectasia. Cell, 86: 159-171, 1996.
40. Hawley, R. S., and Friend, S. H. Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. Genes Dev., 10: 2382-2388, 1996.
41. Wiesmuller, L., Cammenga, J., and Deppert, W. W. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J. Virol., 70: 737-744, 1996.
42. Lee, S., Cavallo, L., and Griffith, J. Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem., 272: 7532-7539, 1997.
43. Bogue, M. A., Zhu, C., Aguilar-Cordova, E., Donehower, L. A., and Roth, D. B. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev., 10: 553-565, 1996.
44. Guidos, J. C., Williams, J. C., Gradal, I., Knowles, G., Huang, T. F. M., and Danska, S. J. V(D)J recombination activates a p53-dependent DNA damage checkpoint in SCID lymphocyte precursors. Genes Dev., 10: 2038-2054, 1996.
45. Nacht, M., Strasser, A., Chan, R. Y., Harris, A. W., Schlissel, M., Bronson, T. R., and Jacks, T. Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev., 10: 2055-2066, 1996.
46. Modrich, P. Mishmatch repair, genetic stability and cancer. Science (Washington DC), 266: 1959-1960, 1994.
47. Selden, J. R., Dolbeare, F., Clair, J. H., Nichols, W. W., Miller, J. E., Kleemeyer, K. M., Hyland, R. J., and DeLuca, J. G. Statistical confirmation that immunofluorescent detection of DNA repair in human fibroblasts by measurement of bromodeoxyuridine incorporation is stoichiometric and sensitive. Cytometry, 14: 154-167, 1993.
48. Almog, N., and Rotter, V. An insight into the life of p53: a protein coping with many functions! Biochim. Biopys. Acta., 1378: R43-R54, 1998.
49. Edelmann, W., Cohen, P. E., Kane, M., Lau, K., Morrow, B., Bennett, S., Umar, A., Kunkel, T., Cattoretti, G., Chaganti, R., Pollard, J. W., Kolodner, R. D., and Kuchertapati, R. Meiotic pachytene arrest in MLH1-deficient mice. Cell, 85: 1125-1134, 1996.
50. Lin, W. W., Lamb, D. J., Wheeler, T. M., Lipshultz, L. I., and Kim, E. D. In situ end-labeling of human testicular tissue demonstrates increased apoptosis in conditions of abnormal spermatogenesis. Fertil. Steril., 68: 1065-1069, 1997.
51. Blanco-Rodriguez, J., and Martinez-Garcia, C. Spontaneous germ cell death in the testis of the adult rat takes the form of apoptosis: re-evaluation of cell types that exhibit the ability to die during spermatogenesis. Cell Prolif., 29: 13-31, 1996.
52. Dallapiccola, B., De Filippis, V. N. A., and Perla, G., Zelante, L. Ring chromosome 21 in healthy persons: different consequences in females and in males. Hum. Genet., 73: 218-220, 1986.
53. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (Washington DC), 282: 1497-1501, 1998.
54. Schwartz, D., Almog, N., Peled, A., Goldfinger, N., and Rotter, V. Role of wild type p53 in the G2 phase: regulation of the γ-irradiation-induced delay and DNA repair. Oncogene, 15: 2597-2607, 1997.
55. Guillouf, C., Rosselli, F., Krishnaraju, K., Moustacchi, E., Hoffman, V., and Liebermann, D. A. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene, 10: 2263-2270, 1995.
56. Hong, J. H., Gatti, R. A., Huo, Y. K., Chiang, C. S., and McBride, W. H. G2/M-phase arrest and release in ataxia-telangiectasia and normal cells after exposure to ionising radiation. Radiat. Res., 140: 17-23, 1994.
57. Kaufmann, W. K., Levedakou, E. N., Grady, H. L., Paules, R. S., and Stein, G. H. Attenuation of G2 checkpoint function precedes human cell immortalization. Cancer Res., 55: 7-11, 1995.
58. Stewart, N., Hicks, G. G., Paraskevas, F., and Mowat, M. Evidence for a second cell cycle block at G2/M by p53. Oncogene, 10: 109-115, 1994.
59. Yin, Y., DeWolf, W. C., and Morgentaler, A. Experimental cryptorchidism induces testicular germ cell apoptosis by p53-dependent and -independent pathways in mice. Biol. Reprod., 58: 492-496, 1998.
60. Wiltshire, T., Park, C., Caldwell, K. A., and Handel, M. A. Induced premature G2/M-phase transition in pachytene spermatocytes includes events unique to meiosis. Dev. Biol., 169: 557-567, 1995.
61. Donehower, L. A., Harvey, M., Slagle, B. T., McArthur, M. J., Montgomery, C. A., Butel, J. S., and Bradly, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.) 356: 215-221, 1992.
62. Timme, T. L., and Thompson, T. C. Rapid allelotype analysis of p53 knockout mice. Bio Techniques, 17: 461-463, 1994.
63. Calamera, J. C., Quiros, M. C., Brugo, S., and Nicholson, R. F. Comparison between swim-up and glass bead column techniques for the separation of human spermatozoa. Andrologia, 23: 259-261, 1991.
64. Darzynkiewicz, Z., Li, X., and Gong, J. Assays of cell viability: discrimination of cell dying by apoptosis. Methods Cell Biol., 41: 15-38, 1994.
65. Darzynkiewicz, Z. Cell cycle analysis by flow cytometry. Cell Biol. Lab. Handbook, 1: 261-271, 1994.
66. Weinbauer, G. F., Schubert, J., Yeung, C. H., Rosiepen, G., and Nieschlag, E. Gonadotrophin-releasing hormone antagonist arrests premeiotic germ cell proliferation but does not inhibit meiosis in the male monkey: a quantitative analysis using 5-bromodeoxyuridine and dual parameter flow cytometry. J. Endocrinol., 156: 23-24, 1998.
67. Clausen, O. P., Berg, K. A., Kirkhus, B., De Angelis, P., and Huitfeldt, H. BrdUrd incorporation studies for evaluation of spermatogenesis in the blue fox. Cytometry, 13: 374-380, 1992.
68. Gasinska, A., and Wilson, G. D. Flow cytometric evaluation of the effects of 2.3 MeV neutrons and 240 kV X rays on mouse spermatogenic S-phase cells using bromodeoxyuridine incorporation. Br. J. Radiol., 61: 133-139, 1988.
69. Wride, M. A., Lapchak, P. H., and Sanders, E. J. Distribution of TNF α-like proteins correlates with some regions of programmed cell death in the chick embryo. Int. J. Dev. Biol., 38: 673-682, 1994.